High baseline sPD-L1 was also correlated with worse distant metastasis-free survival (74.0% vs 87.5% rate at 4 years) after radiotherapy or chemo-radiotherapy in nasopharyngeal carcinoma patients [55]. The gene discussed is SPDL1; the disease is nasopharyngeal carcinoma.